John W. Beck, CFO at METABASIS THERAPEUTICS INC (MBRX), sold 500 shares at $8.01 ($4K) on 2006-11-27, disclosed to the SEC on 2006-11-29.
Scheduled sale ($4k) by CFO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.00 | 100 | $800 | 20.0% |
| 2 | $8.01 | 200 | $2K | 40.0% |
| 3 | $8.02 | 200 | $2K | 40.0% |
| Total | $8.01 avg | 500 | $4K | 100% |
| Filing → |
| RDEA | SELL | 2009-08-17 | $50K | — | Filing → |
| RDEA | SELL | 2009-05-21 | $75K | — | Filing → |
| MBRX | SELL | 2007-06-21 | $27K | — | Filing → |